AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17131168 — intervention group
Group type: COMPARATOR
Intervention: Microtip transducer catheter
Number of subjects: 18
Study 15962224 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-drug antiretroviral regimen
Number of subjects: 175
Study 12870834 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF DPI) 400 microg twice daily
Number of subjects: 132
Study 12870834 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF DPI) 800 microg twice daily
Number of subjects: 132
Study 12870834 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF DPI)
Number of subjects: 132
Study 12870834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 10229468 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous gastrojejunostomy (PGJ)
Number of subjects: 135
Study 10229468 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 135
Study 8966391 — intervention group
Group type: COMPARATOR
Intervention: Busulfan
Number of subjects: 30
Study 8966391 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfa-interferon plus busulfan
Number of subjects: 30
Study 1714697 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk infant formula with 40 mg Fe/100 g
Number of subjects: 149
Study 1714697 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk infant formula with 8.3 mg Fe/100 g
Number of subjects: 149
Study 6667621 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestasert IUD
Number of subjects: 0
Study 6667621 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiload Cu 250 IUD
Number of subjects: 0
Study 6667621 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sterilization
Number of subjects: 0
Study 6667621 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31688194 — intervention group
Group type: EXPERIMENTAL
Intervention: Online virtual mechanical ventilation simulator before clinical rotation
Number of subjects: 483
Study 31688194 — intervention group
Group type: EXPERIMENTAL
Intervention: Online virtual mechanical ventilation simulator after clinical rotation
Number of subjects: 483
Study 31688194 — intervention group
Group type: COMPARATOR
Intervention: Clinical rotation
Number of subjects: 483
Study 31688194 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention
Number of subjects: 483
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanitation
Number of subjects: 5551
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing
Number of subjects: 5551
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, and handwashing
Number of subjects: 5551
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition
Number of subjects: 5551
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, handwashing, and nutrition
Number of subjects: 5551
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Water treatment
Number of subjects: 5551
Study 29396217 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 5551
Study 29396217 — intervention group
Group type: EXPERIMENTAL
Intervention: Water, sanitation, and handwashing
Number of subjects: 5551
Study 26743348 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin reload (AR) 80 mg 12 hours before + 40 mg 2 hours before PCI
Number of subjects: 53
Study 26743348 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin reload (AR)
Number of subjects: 53
Study 26743348 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 53
Study 25713015 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient controlled remifentanil
Number of subjects: 1414
Study 25713015 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 1414
Study 25713015 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 1414
Study 23702720 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused rigidity casts (FRCs)
Number of subjects: 31
Study 23702720 — intervention group
Group type: COMPARATOR
Intervention: Control (canvas shoe)
Number of subjects: 31
Study 20558006 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg)
Number of subjects: 28
Study 20558006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 20558006 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg and 10 mg)
Number of subjects: 28
Study 18644681 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral self-help program for smoking cessation
Number of subjects: 200
Study 18089905 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated drink (5 mg/kg)
Number of subjects: 52
Study 18089905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 14551176 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone
Number of subjects: 5
Study 14551176 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 5
Study 14551176 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 5
Study 14551176 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 5
Study 14551176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 10925490 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracision
Number of subjects: 34
Study 10925490 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemostasis
Number of subjects: 34
Study 8648202 — intervention group
Group type: EXPERIMENTAL
Intervention: ca A/Los Angeles/2/87 (H3N2) vaccine
Number of subjects: 182
Study 8648202 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent ca vaccine
Number of subjects: 182
Study 8648202 — intervention group
Group type: EXPERIMENTAL
Intervention: monovalent ca H1N1 vaccine
Number of subjects: 182
Study 8648202 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 182
Study 1378690 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (i.v.) given for 14-28 days
Number of subjects: 0
Study 1378690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6652008 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 37
Study 6652008 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 37
Study 6652008 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 37
Study 6652008 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 37
Study 6652008 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 37
Study 31638498 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower protein content formula during the 1st year of life
Number of subjects: 0
Study 31638498 — intervention group
Group type: COMPARATOR
Intervention: Higher protein content formula during the 1st year of life
Number of subjects: 0
Study 30092876 — intervention group
Group type: EXPERIMENTAL
Intervention: LF-LAM
Number of subjects: 1307
Study 26666688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy‐guided self‐help manual
Number of subjects: 54
Study 26666688 — intervention group
Group type: COMPARATOR
Intervention: Standard support (control)
Number of subjects: 54
Study 25133164 — intervention group
Group type: EXPERIMENTAL
Intervention: Green coffee (GC)
Number of subjects: 0
Study 25133164 — intervention group
Group type: EXPERIMENTAL
Intervention: Black coffee (BC)
Number of subjects: 0
Study 22417778 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteroides xylanisolvens DSM 23964 (8.5×10^11 cells) in pasteurised fermented milk for 3 weeks
Number of subjects: 181
Study 22417778 — intervention group
Group type: COMPARATOR
Intervention: Bacteroides xylanisolvens DSM 23964 (10^12 cells) in spray-dried fermented milk for 6 weeks
Number of subjects: 181
Study 19959734 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 12
Study 19959734 — intervention group
Group type: COMPARATOR
Intervention: Placebo alcohol (Control)
Number of subjects: 12
Study 17049883 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental investigation of perceptual experience after stroke
Number of subjects: 1
Study 15024563 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 ml (15 mg) 0.5% hyperbaric bupivacaine (bilateral group)
Number of subjects: 70
Study 15024563 — intervention group
Group type: COMPARATOR
Intervention: 1.5 ml (7.5 mg) 0.5% hyperbaric bupivacaine (unilateral group)
Number of subjects: 70
Study 12350190 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program (n = 447)
Number of subjects: 1113
Study 12350190 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n = 303)
Number of subjects: 1113
Study 12350190 — intervention group
Group type: COMPARATOR
Intervention: PEFR monitoring control group (n = 363)
Number of subjects: 1113
Study 9843464 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 40895
Study 9843464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained VT/VF
Number of subjects: 40895
Study 9843464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained VT and VF
Number of subjects: 40895
Study 9843464 — intervention group
Group type: COMPARATOR
Intervention: Surviving hospitalization
Number of subjects: 40895
Study 8080374 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated bypass to the superior mesenteric artery (SMA)
Number of subjects: 26
Study 2511696 — intervention group
Group type: EXPERIMENTAL
Intervention: pentaerythrityltetranitrate (PETN) 50-300 mg
Number of subjects: 24
Study 2511696 — intervention group
Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate (ISDN) 40-120 mg
Number of subjects: 24
Study 2511696 — intervention group
Group type: COMPARATOR
Intervention: sublingual nitroglycerin
Number of subjects: 24
Study 2511696 — intervention group
Group type: EXPERIMENTAL
Intervention: long-acting nitrates (PETN and ISDN)
Number of subjects: 24
Study 981634 — intervention group
Group type: EXPERIMENTAL
Intervention: Large daily fractions of 400 rads/day for 10-12 treatments
Number of subjects: 0
Study 981634 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation schedules using 200 rads/day
Number of subjects: 0
Study 31123053 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study 31123053 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel pharmacologic therapeutics
Number of subjects: 0
Study 31123053 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 28215827 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting and decision support intervention (16-week program with one in-person session and seven biweekly telephone coaching calls)
Number of subjects: 54
Study 28215827 — intervention group
Group type: COMPARATOR
Intervention: Control group (information about local health care resources on the same contact schedule)
Number of subjects: 54
Study 28215827 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 54
Study 25886178 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised Feedback and Brief Advice (PFBA)
Number of subjects: 1500
Study 25886178 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised Feedback plus electronic Brief Intervention (eBI)
Number of subjects: 1500
Study 25886178 — intervention group
Group type: COMPARATOR
Intervention: Screening alone (Control)
Number of subjects: 1500
Study 24083440 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain MRI to determine the presence of brain infarcts and other cerebrovascular lesions (brain microbleeds, white matter changes, enlarged perivascular spaces)
Number of subjects: 1000
Study 24083440 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of other organ damage (heart-left ventricular hypertrophy, kidney-urine albumin to creatinine ratio, vessels-pulse wave velocity, ankle brachial index)
Number of subjects: 1000
Study 24083440 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up for at least 3 years
Number of subjects: 1000
Study 20966122 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril + Losartan
Number of subjects: 0
Study 20966122 — intervention group
Group type: COMPARATOR
Intervention: Enalapril + Placebo
Number of subjects: 0
Study 19565422 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 50
Study 19565422 — intervention group
Group type: COMPARATOR
Intervention: Depot-medroxyprogesterone acetate (DMPA)
Number of subjects: 50
Study 17103417 — intervention group
Group type: COMPARATOR
Intervention: Placebo response (PRs)
Number of subjects: 451
Study 17103417 — intervention group
Group type: COMPARATOR
Intervention: Follow-up of placebo responders (PRs)
Number of subjects: 451
Study 17103417 — intervention group
Group type: COMPARATOR
Intervention: Nonresponders (NRs)
Number of subjects: 451
Study 14766942 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill running (8 deg)
Number of subjects: 19
Study 14766942 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill running (4 deg)
Number of subjects: 19
Study 14766942 — intervention group
Group type: EXPERIMENTAL
Intervention: Uphill running (4 deg)
Number of subjects: 19
Study 14766942 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 11551733 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-session CBT program (6CBT)
Number of subjects: 229
Study 11551733 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-session CBT intervention (1CBT)
Number of subjects: 229
Study 11551733 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment control (DTC)
Number of subjects: 229
Study 9704701 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged heparin infusion after PTCA
Number of subjects: 191
Study 9704701 — intervention group
Group type: COMPARATOR
Intervention: No postprocedure heparin (control group)
Number of subjects: 191
Study 7991318 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of stress experienced while officiating
Number of subjects: 782
Study 2656766 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride-stannous fluoride mouthrinse
Number of subjects: 16
Study 2656766 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthrinse
Number of subjects: 16
Study 29135600 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi training program (16 weeks)
Number of subjects: 29
Study 29135600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Tai Chi training)
Number of subjects: 29
Study 28489637 — intervention group
Group type: EXPERIMENTAL
Intervention: Open tracheal suctioning
Number of subjects: 24
Study 28489637 — intervention group
Group type: COMPARATOR
Intervention: Closed tracheal suctioning
Number of subjects: 24
Study 25491493 — intervention group
Group type: EXPERIMENTAL
Intervention: Eluxadoline (200 mg dose) coadministered with cyclosporine
Number of subjects: 0
Study 25491493 — intervention group
Group type: EXPERIMENTAL
Intervention: Eluxadoline (200 mg dose) coadministered with probenecid
Number of subjects: 0
Study 22777107 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk drinking yogurts enriched with phytosteryl/‐stanyl fatty acid esters
Number of subjects: 0
Study 22777107 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk drinking yogurts enriched with ferulates
Number of subjects: 0
Study 20798655 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of calcium 20 min before exercise
Number of subjects: 20
Study 20798655 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg of calcium every 15 min during exercise (1000 mg total)
Number of subjects: 20
Study 20798655 — intervention group
Group type: COMPARATOR
Intervention: Placebo before and during exercise
Number of subjects: 20
Study 19244379 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake
Number of subjects: 0
Study 16420509 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% human albumin
Number of subjects: 68
Study 16420509 — intervention group
Group type: COMPARATOR
Intervention: 3.5% polygeline (synthetic colloid)
Number of subjects: 68
Study 12956861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IgG) at doses of 1, 5, and 10 mg/ml
Number of subjects: 25
Study 12058972 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflict resolution and peer mediation training integrated into social studies curriculum for 5 weeks (105 min every other day)
Number of subjects: 0
Study 12058972 — intervention group
Group type: COMPARATOR
Intervention: Control group studying the same social studies curriculum without conflict resolution and peer mediation training
Number of subjects: 0
Study 12058972 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflict resolution and peer mediation training integrated into social studies curriculum
Number of subjects: 0
Study 9717348 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Education (HE) monitored with group session and postal back-up
Number of subjects: 110
Study 9717348 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE) from family doctor
Number of subjects: 110
Study 7644452 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide quit-smoking contests
Number of subjects: 11
Study 2707117 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 g sucrose during a mixed meal (meal A)
Number of subjects: 6
Study 2707117 — intervention group
Group type: COMPARATOR
Intervention: Saccharin during a mixed meal (meal B)
Number of subjects: 6
Study 367726 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐carboxymethylcysteine (2 grams)
Number of subjects: 22
Study 367726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30604663 — intervention group
Group type: COMPARATOR
Intervention: Active Control (non‐nutrition, ‐physical activity (PA), ‐mental health)
Number of subjects: 87
Study 30604663 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (nutrition and PA)
Number of subjects: 87
Study 30604663 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care (nutrition and PA, plus cognitive behavioural techniques)
Number of subjects: 87
Study 29116298 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% titanium tetrafluoride (TiF 4) varnish
Number of subjects: 12
Study 29116298 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride (NaF) varnish
Number of subjects: 12
Study 29116298 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 12
Study 29116298 — intervention group
Group type: COMPARATOR
Intervention: Negative control (deionized water)
Number of subjects: 12
Study 25293368 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03B-adjuvanted H5N1 influenza vaccine (1.9 µg of hemagglutinin and 5.93 mg of α-tocopherol)
Number of subjects: 0
Study 25293368 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03B-adjuvanted H5N1 influenza vaccine
Number of subjects: 0
Study 25293368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23504641 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework compliance quality
Number of subjects: 292
Study 23504641 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure homework
Number of subjects: 292
Study 23504641 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework relating to psychoeducation and self‐monitoring
Number of subjects: 292
Study 21730902 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature Infant Oral Motor Intervention (PIOMI) for 5 minutes per day for 7 consecutive days
Number of subjects: 19
Study 21730902 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (control group)
Number of subjects: 19
Study 19589539 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (3000 ng intra-arterial bolus over 1 to 3 min immediately after revascularization)
Number of subjects: 30
Study 19589539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 16364360 — intervention group
Group type: EXPERIMENTAL
Intervention: Vowel context usage when spelling word-final consonants (codas)
Number of subjects: 0
Study 16364360 — intervention group
Group type: EXPERIMENTAL
Intervention: Vowel context usage when spelling word-initial consonants (onsets)
Number of subjects: 0
Study 14702450 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (10-minute training session and handout on using a pediatric digital library)
Number of subjects: 52
Study 14702450 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study 14702450 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups used computers and digital libraries to answer questions
Number of subjects: 52
Study 12575371 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuelong Granule (XLG)
Number of subjects: 98
Study 12575371 — intervention group
Group type: COMPARATOR
Intervention: Shenchai Granule
Number of subjects: 98
Study 12575371 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuelong Granule (XLG) in experimental study on model rats
Number of subjects: 98
Study 9282969 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (6 g/h)
Number of subjects: 7
Study 9282969 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 7
Study 8332150 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 486
Study 8332150 — intervention group
Group type: COMPARATOR
Intervention: Other antiarrhythmic drugs combined
Number of subjects: 486
Study 31387766 — intervention group
Group type: EXPERIMENTAL
Intervention: Firearm safety message only (n = 115)
Number of subjects: 358
Study 31387766 — intervention group
Group type: EXPERIMENTAL
Intervention: Firearm safety and mental health promotion messages (n = 133)
Number of subjects: 358
Study 31387766 — intervention group
Group type: COMPARATOR
Intervention: Active control group exposed to mental health promotion message only (n = 110)
Number of subjects: 358
Study 29225161 — intervention group
Group type: EXPERIMENTAL
Intervention: General Self-Efficacy (GSE) scale assessment
Number of subjects: 456
Study 29225161 — intervention group
Group type: EXPERIMENTAL
Intervention: General Self-Efficacy (GSE) scale assessment with interaction terms
Number of subjects: 456